The University of Richmond is committed to developing and maintaining an environment that encourages students participating in intercollegiate athletic competition to avoid the abuse of alcohol and the unauthorized use of controlled substances and performance-enhancing drugs. The integration of a comprehensive educational program with reliable tests and predictable responses to student-athletes who test positive will function as an effective deterrent to substance abuse.
To this end, the program has several components. The education program is designed to discourage student-athletes from alcohol abuse and experimentation with drugs and minimize the risk of drug abuse and drug dependency. An accurate and reliable drug screening program will identify users and abusers of controlled substances and performance-enhancing drugs. Student-athletes who test positive will participate in a program designed to encourage the student-athlete to make positive choices about his or her future conduct, and to discipline those student-athletes who continue to abuse controlled substances and performance-enhancing drugs.
II. POLICY
The unauthorized use of anabolic steroids, stimulants, diuretics, performance enhancing drugs, marijuana, cocaine, amphetamines and any other substance proscribed by federal or state law, or the abuse of alcohol by any member of an intercollegiate athletic team at University of Richmond is expressly prohibited, regardless of whether such use or abuse occurs before, during or after the team's competitive season. "Proscribed substances" as that phrase appears in this Policy Statement include but are not limited to those drugs listed in NCAA Executive Regulations, 31.2.3.1 as adopted in 1986 and as may be amended from time to time (copy attached).
The unauthorized use of the proscribed substances or abuse of alcohol constitutes an abuse of the privilege of practicing for and representing University of Richmond in intercollegiate athletics competition. Such unauthorized use or abuse may result in sanctions, including dismissal from intercollegiate athletic teams, lost of a student-athlete's athletic grant-in-aid, and a permanent prohibition against competing in the intercollegiate athletics program at University of Richmond.
All student-athletes engaged in the intercollegiate athletics program shall participate in a drug and alcohol education program. All student-athletes shall provide urine specimens upon notice from an appropriate official within the Department of Athletics. Said sample shall be subject to analysis by a professional testing laboratory to screen student-athletes to determine use of the proscribed substances. Each student-athlete shall, prior to participating in any sport, acknowledge in writing that he or she has received a copy of this Policy Statement, and shall consent to participate in the drug screening and education program, including but not limited to consenting to the collection of urine to be tested for the presence of the above-referenced proscribed substances.
The program will be designed to protect the confidentiality of data and to assure that information regarding individual student-athletes will not be transmitted to individuals who have neither a right nor a need to know, except as set forth herein.
III. SAMPLES.
The University of Richmond Department of Athletics shall from time to time collect urine samples from student-athletes. Samples to be screened and tested in order to detect the presence of proscribed substances shall be selected at random. Alternatively, if the Director of Athletics has reason to believe that a student-athlete or members of a particular team have been abusing proscribed substances, he/she may mandate that an entire team or an individual be tested. The decision to test any team or individual athlete as a result of this procedure shall rest entirely with the Director of Athletics, who may consult with members of the University's Sports Medicine staff. If the Director of Athletics decides to test any individual student-athlete, the Director shall so advise the Drug Program Administrator, who shall notify the student-athlete. Student-athletes will be advised of the designated time and location for the submission of urine samples. Coaches shall not be notified of the decision to test any team or individual. If the student-athlete fails to submit a urine sample within the designated testing period, he/she will enter be deemed to have produced a positive test sample.
All student-athletes who qualify to participate in NCAA post-season National Championship competition may be tested prior to the onset of such competition.
Following the selection of a qualified drug-testing laboratory, procedures will be established regarding the collection of samples, security of samples, retention of samples for retesting and validity of the laboratory and testing results.
IV. PRE-SANCTION APPEAL.
A student-athlete who contests a laboratory finding that he/she has a proscribed substance in his/her urine sample, may within thirty (30) days following receipt of notice of said laboratory finding, present evidence of the inaccuracy of said finding to the Drug Program Administrator. Upon request from the student-athlete, the Drug Program Administrator shall provide him/her with the names of laboratories determined by the University to be capable of analyzing urine samples for the presence of proscribed substances. The student-athlete may authorize the transmission of his/her urine sample from the laboratory retained by the University to any one of the laboratories identified by the Drug Program Administrator, and shall further authorize the transmission of test results from the laboratory of his/her choice to the Drug Program Administrator.
If the laboratory selected by the student-athlete presents to the Drug Program Administrator a finding that the student-athlete does not have proscribed substances in his/her urine sample, the Drug Program Administrator must rely upon those test results and shall conclude that the student-athlete's urine does not contain proscribed substances.
A student-athlete may present evidence of mitigating circumstances to the Director of Athletics who in his discretion may modify the sanctions set forth in Section V herein.
V. POST-TEST PROCEDURES; SANCTIONS.
VI. AMENDMENTS.
This program may be amended from time to time at the discretion of the Director of Athletics. Amendments shall be distributed to all student-athletes. No amendment shall be applied retroactively if such application will adversely effect a student-athlete's right to prior notice of standards of conduct or discipline.
The Executive Committee shall authorize methods for drug testing of student-athletes who compete in NCAA championships and certified post-season football contests. The authorized methods, and any subsequent modifications, shall be published in The NCAA News and copies of the report shall be available, on request, to member institutions. The Executive Committee shall determine those championships and certified post-season football contests for which drug tests shall be made and the procedures to be followed in disclosing its determinations.
31.2.3.1 Banned Drugs. The following is the list of banned-drug classes:
(1) Psychomotor and central nervous system stimulants:
amiphenazole meclofenoxate
amphetamine methamphetamine
bemigride methylphenidate
benzphetamine nikethamide
caffeine pemoline
chlorphentermine pentetrazol
cocaine phendimetrazine
cropropamide phenmetrazine
crothetamide phentermine
diethylpropion picrotoxine
dimethyl amphetamine pipradol
doxapram prolintane
ephedrwe
ethamivan strychnine
ethyl amphetamine AND RELATED COMPOUNDS
fencamfamine
(2) Anabolic steroids:
androstenedione
boldenone nandrolone
clostebol Norandrostenedione
clenbuterol
dehydrochlormethyl- norethandrolone
testosterone nandrolone
dehydroepiandrosterone oxandrolone
dihydrotestosterone
dromostanolone oxymesterone
fluoxymesterone oxymetholone
mesterolone stanozolol
methenolone testosterone
methandienone AND RELATED COMPOUNDS
methyltestosterone Other anablic agents: Clenbuterol
(3) Diuretics:
acetazolamide hydroflumethiazide
bendroflumethiazide methyclothiazide
benzthiazide metolazone
Bumetanide
chlorothiazide polythiazide
chlorthalidone quinethazone
ethacrynic acid spironolactone
flumethiazide triamterene
furosemide trichlormethiazide
hydrochlorothiazide AND RELATED COMPOUNDS
(4) Street drugs:
heroin marijuana
THC (tetrahydrocannabinol)3
(5) Peptide hormones and analogues
chorionic gonadotrophin (HCG - human chorionic gonadotrophin)
corticotrophine (ACTH)
erythropoietin (EPO)
growth hormone (HGH, somatotrophin)
*All the respective releasing factors of the above-mentioned substances also are banned.
Definition of positive depends on the following: